Prospective clinical study of tacrolimus ointment combined with swellable microneedles in the treatment of psoriasis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2500096255

Enrollment

Unknown

Registered

2025-01-21

Start date

2025-02-03

Completion date

Unknown

Last updated

2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriasis

Interventions

experimental group:swellable microneedles combined with tacrolimus ointment for external use

control group :Apply tacrolimus ointment alone

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for plaque psoriasis in Chinese Psoriasis Diagnosis and Treatment Guidelines (2023 Complete Edition); 2. The psoriasis lesion area and severity index PASI are less than 10 points; 3. Aged between 18 and 75 years old, either male or female; 4. The patient has given informed consent to this study.

Exclusion criteria

Exclusion criteria: 1. Have a history of mental illness and refuse to cooperate with treatment; 2. Combined with other skin diseases or serious infections.

Design outcomes

Primary

Measure	Time frame
psoriasis area and severity index;	—

Secondary

Measure	Time frame
PGA rating;DLQI;	—

Countries

China

Contacts

Public ContactXu Min

Chu Hsien-I Memorial Hospital of Tianjin Medical University

18002180062@163.com+86 180 0218 0062

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026